BioSpace News Archive

Akari Therapeutics, Plc and Peak Bio Inc. announce a definitive agreement to merge as equals in an all-stock transaction.

Allergan Aesthetics, an AbbVie company, announced the U.S. FDA approval of JUVÉDERM® VOLUMA® XC for injection in the temple region to improve moderate to severe temple hollowing in adults over the age of 21.

YS Biopharma Co., Ltd. today announced changes to its board of directors (the “Board”) and key strategic appointments within its wholly-owned subsidiaries in China.

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (“BioVaxys” or “Company”) announced that it has received a Notice of Allowance from the Japanese Patent Office for a Patent (“Patent”) for inducing an antibody immune response from a low dose volume delivery of a B-cell epitope formulated with DPX™.

Elysium Therapeutics today announced positive results from a Phase 1, human-proof-of-concept study (O2P-001) investigating the company’s proprietary Oral Overdose Protected (O2P™) hydrocodone prodrug for the treatment of moderate-to-severe acute pain.

Tevogen Bio Holdings, congratulates Victor Sordillo PE, CSP, MBA, on his recent appointment as Managing Director of Risk Advisory Services at Verita CSG, Inc., a provider of holistic insurance and risk management solutions for commercial line clients.

Endologix LLC announced the appointment of Mike Mathias as the company’s Chief Commercial Officer, effective immediately.

Ankyra Therapeutics today announced the first patient dosed in the dose escalation cohort in a Phase 1 clinical study evaluating ANK-101, a tumor-directed, anchored immune medicine for solid tumors.

Bone Health Technologies announced the company has raised a new $5 million funding round from leading investment firms, including Esplanade Ventures, Berkeley Catalyst Fund, as well as strategic investor and leading global medical technology provider Terumo Medical.

Mirum Pharmaceuticals, Inc. today announced that it will participate in the following upcoming investor conferences.